Romania

The Romanian life sciences ecosystem has emerged as a resilient and high-growth corridor within Central and Eastern Europe, bridging the gap between cost-efficient manufacturing and healthcare innovation.

The country is best known for its robust pharmaceutical industry, boasting a mix of legacy domestic producers and major multinational manufacturing plants that export generic medicines and high-value formulations globally.

Romania is increasingly recognized for its biotechnology potential, particularly in industrial applications and emerging biopharmaceutical R&D centered in academic hubs like Bucharest and Cluj-Napoca.

The medical device sector is undergoing a digital transformation, fueled by the nation's renowned IT expertise, leading to breakthroughs in healthtech and telemedicine solutions.

Furthermore, clinical trials in Romania offer a competitive landscape for global CROs due to a diverse patient pool and a highly skilled, multilingual medical workforce.

Academic research remains a cornerstone of the ecosystem, with prestigious medical universities driving advancements in genomics, molecular biology and regenerative medicine.

The rise of specialized life sciences clusters fosters essential public-private partnerships, accelerating the commercialization of biotech startups and medical innovations.

As healthcare expenditure continues to rise, the domestic market is modernizing through the adoption of e-health infrastructure and personalized medicine.

With a strategic focus on pharmaceutical supply chain resilience and digital health, Romania is positioning itself as a vital node for international investors and scientific collaborators.